Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A05479 | 33242590 | Biochim Biophys Acta Mol Basis Dis | Regulation of autophagy by bile acids and in cholestasis - CholestoPHAGY or CholeSTOPagy. | 2020 | Details |
| A05480 | 33241206 | JHEP Rep | Organoids to model liver disease. | 2020 | Details |
| A05481 | 33240906 | Front Med (Lausanne) | CML/RAGE Signal Bridges a Common Pathogenesis Between Atherosclerosis and Non-alcoholic Fatty Liver. | 2020 | Details |
| A05482 | 33239899 | Diabetes Metab Syndr Obes | CHDH-PNPLA3 Gene-Gene Interactions Predict Insulin Resistance in Children with Obesity. | 2020 | Details |
| A05483 | 33239040 | Lipids Health Dis | Association between the alanine aminotransferase/aspartate aminotransferase ratio and new-onset non-alcoholic fatty liver disease in a nonobese Chinese population: a population-based longitudinal study. | 2020 | Details |
| A05484 | 33238880 | Mol Med | Hepatocyte high-mobility group box 1 protects against steatosis and cellular stress during high fat diet feeding. | 2020 | Details |
| A05485 | 33236464 | Diabetes Obes Metab | Metformin dose increase versus added linagliptin in non-alcoholic fatty liver disease and type 2 diabetes: An analysis of the J-LINK study. | 2020 | Details |
| A05486 | 33236445 | Hepatology | Myeloid-Cell-Specific IL-6 Signaling Promotes MicroRNA-223-Enriched Exosome Production to Attenuate NAFLD-Associated Fibrosis. | 2021 | Details |
| A05487 | 33236409 | Hepatology | Transient Versus Two-Dimensional Shear-Wave Elastography in a Multistep Strategy to Detect Advanced Fibrosis in NAFLD. | 2021 | Details |
| A05488 | 33235477 | Diabetes Metab Syndr Obes | Elevated TPOAb is a Strong Predictor of Autoimmune Development in Patients of Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Case-Control Study. | 2020 | Details |
| A05489 | 33235221 | Nat Commun | Intestinal FGF15/19 physiologically repress hepatic lipogenesis in the late fed-state by activating SHP and DNMT3A. | 2020 | Details |
| A05490 | 33235107 | Medicine (Baltimore) | Usefulness of controlled attenuation parameter and liver stiffness measurement for detecting increased arterial stiffness in asymptomatic populations in China. | 2020 | Details |
| A05491 | 33235066 | Medicine (Baltimore) | A nomogram for estimating the probability of nonalcoholic fatty liver disease in a Chinese population: A retrospective cohort study. | 2020 | Details |
| A05492 | 33234776 | Curr Opin Lipidol | Liver fat storage pathways: methodologies and dietary effects. | 2021 | Details |
| A05493 | 33234364 | Phytomedicine | Naringenin alleviates nonalcoholic steatohepatitis in middle-aged Apoe-/-mice: role of SIRT1. | 2020 | Details |
| A05494 | 33234342 | Clin Nutr | Mediterranean diet is inversely associated with steatosis and fibrosis and decreases ten-year diabetes and cardiovascular risk in NAFLD subjects: Results from the ATTICA prospective cohort study. | 2020 | Details |
| A05495 | 33233601 | Diagnostics (Basel) | Circulating Bile Acids Profiles in Obese Children and Adolescents: A Possible Role of Sex, Puberty and Liver Steatosis. | 2020 | Details |
| A05496 | 33232883 | Eur J Cell Biol | Causative and Sanative dynamicity of ChREBP in Hepato-Metabolic disorders. | 2020 | Details |
| A05497 | 33232525 | J Gastroenterol Hepatol | FibroScan-aspartate aminotransferase score in an Asian cohort of non-alcoholic fatty liver disease and its utility in predicting histological resolution with bariatric surgery. | 2020 | Details |
| A05498 | 33230078 | J Pediatr Gastroenterol Nutr | Performance Characteristics, Intra- and Inter-operator Agreement of Transient Elastography in Pediatric Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A05499 | 33229553 | Proc Natl Acad Sci U S A | Triclosan leads to dysregulation of the metabolic regulator FGF21 exacerbating high fat diet-induced nonalcoholic fatty liver disease. | 2020 | Details |
| A05500 | 33228663 | J Transl Med | LncRNA NEAT1/microRNA-129-5p/SOCS2 axis regulates liver fibrosis in alcoholic steatohepatitis. | 2020 | Details |
| A05501 | 33228237 | Int J Mol Sci | Nutrients, Genetic Factors, and Their Interaction in Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease. | 2020 | Details |
| A05502 | 33228201 | Diagnostics (Basel) | Chemerin Is a Valuable Biomarker in Patients with HCV Infection and Correlates with Liver Injury. | 2020 | Details |
| A05503 | 33227430 | Clin Gastroenterol Hepatol | Agreement Between the Prevalence of Nonalcoholic Fatty Liver Disease Determined by Transient Elastography and Fatty Liver Indices. | 2020 | Details |
| A05504 | 33227291 | Biochem Pharmacol | Aryl hydrocarbon receptor (AHR), integrating energy metabolism and microbial or obesity-mediated inflammation. | 2020 | Details |
| A05505 | 33227217 | J Med Food | Whole Red Raspberry (Rubus idaeus)-Enriched Diet Is Hepatoprotective in the Obese Zucker Rat, a Model of the Metabolic Syndrome. | 2020 | Details |
| A05506 | 33225408 | Obes Surg | Are We Ready for Bariatric Surgery in a Liver Transplant Program? A Meta-Analysis. | 2020 | Details |
| A05507 | 33224584 | Am J Cardiovasc Dis | Sex differences in cardiovascular diseases and associated risk factors in non-alcoholic steatohepatitis. | 2020 | Details |
| A05508 | 33224193 | Gastroenterol Res Pract | Circulating Irisin Levels in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. | 2020 | Details |
| A05510 | 33222696 | Lipids Health Dis | Association between the non-HDL-cholesterol to HDL-cholesterol ratio and non-alcoholic fatty liver disease in Chinese children and adolescents: a large single-center cross-sectional study. | 2020 | Details |
| A05511 | 33222473 | Rev Esp Enferm Dig | Overall clinical and economic impact of non-alcoholic fatty liver disease. | 2021 | Details |
| A05512 | 33221744 | Aging (Albany NY) | Hsa_circ_0048179 attenuates free fatty acid-induced steatosis via hsa_circ_0048179/miR-188-3p/GPX4 signaling. | 2020 | Details |
| A05513 | 33220986 | Chemosphere | Association between environmental exposure to cadmium and risk of suspected non-alcoholic fatty liver disease. | 2020 | Details |
| A05514 | 33220492 | Mol Metab | Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans. | 2020 | Details |
| A05515 | 33220489 | Mol Metab | Nuclear receptors and transcriptional regulation in non-alcoholic fatty liver disease. | 2020 | Details |
| A05516 | 33220425 | Free Radic Biol Med | Physiological evidence of mitochondrial permeability transition pore opening caused by lipid deposition leading to hepatic steatosis in db/db mice. | 2020 | Details |
| A05517 | 33220422 | Pharmacol Res | Ugonin J improves metabolic disorder and ameliorates nonalcoholic fatty liver disease by regulating the AMPK/AKT signaling pathway. | 2020 | Details |
| A05520 | 33220154 | Liver Int | The NAFLD-MAFLD debate: Eminence vs evidence. | 2020 | Details |
| A05521 | 33220028 | Med Ultrason | Ultrasound-Guided Attenuation Parameter (UGAP) for the quantification of liver steatosis using the Controlled Attenuation Parameter (CAP) as the reference method. | 2020 | Details |
| A05522 | 33219985 | Indian J Gastroenterol | Association between anti-acid therapies and advanced fibrosis in type 2 diabetics with biopsy-proven non-alcoholic fatty liver disease. | 2020 | Details |
| A05523 | 33219609 | Liver Int | Serum aromatic and branched-chain amino acids associated with NASH demonstrate divergent associations with serum lipids. | 2020 | Details |
| A05524 | 33219119 | BMJ Open Diabetes Res Care | Role of ceramide-to-dihydroceramide ratios for insulin resistance and non-alcoholic fatty liver disease in humans. | 2020 | Details |
| A05525 | 33218405 | Taiwan J Obstet Gynecol | Elevated serum levels of galectin-3 binding protein are associated with insulin resistance in non-diabetic women after menopause. | 2020 | Details |
| A05526 | 33218301 | BMC Fam Pract | Non-alcoholic fatty liver disease (NAFLD) and the cardiovascular disease (CVD) risk categories in primary care: is there an association? | 2020 | Details |
| A05527 | 33218081 | Biology (Basel) | Organismal Fructose Metabolism in Health and Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A05528 | 33218077 | Int J Mol Sci | PNPLA3 I148M Up-Regulates Hedgehog and Yap Signaling in Human Hepatic Stellate Cells. | 2020 | Details |
| A05529 | 33217835 | Medicine (Baltimore) | Effects of acupuncture for nonalcoholic fatty liver disease: A protocol for systematic review and meta-analysis. | 2020 | Details |
| A05530 | 33217178 | Liver Transpl | Nonalcoholic Fatty Liver Disease and Diabetes Mellitus Are Associated With Post-Transjugular Intrahepatic Portosystemic Shunt Renal Dysfunction: An Advancing Liver Therapeutic Approaches Group Study. | 2021 | Details |
| A05532 | 33217052 | J Gastroenterol Hepatol | A review of non-alcoholic fatty liver disease in non-obese and lean individuals. | 2020 | Details |
| A05533 | 33216772 | PLoS One | Performance of serum apolipoprotein-A1 as a sentinel of Covid-19. | 2020 | Details |
| A05534 | 33216477 | Eur J Gastroenterol Hepatol | High rates of ineligibility for participation in trials of new therapies in non-alcoholic steatohepatitis: a systematic review. | 2020 | Details |
| A05535 | 33216087 | Food Funct | Amelioration of non-alcoholic fatty liver disease by sodium butyrate is linked to the modulation of intestinal tight junctions in db/db mice. | 2020 | Details |
| A05536 | 33215899 | Transplantation | Live Confocal Imaging as a Novel Tool to Assess Liver Quality: Insights From a Murine Model. | 2020 | Details |
| A05537 | 33215434 | Eur Rev Med Pharmacol Sci | Energy-restricted Central-European diet stimulates liver microsomal function in obese postmenopausal women - a randomized nutritional trial with a comparison to energy-restricted Mediterranean diet. | 2020 | Details |
| A05538 | 33215420 | Eur Rev Med Pharmacol Sci | RNF6 serves as a diagnostic hallmark of non-alcoholic fatty liver disease with hepatocellular carcinoma: a clinical research. | 2020 | Details |
| A05539 | 33214928 | J Thorac Dis | Sleep disorder in patients with chronic liver disease: a narrative review. | 2020 | Details |
| A05540 | 33214329 | Pediatrics | Incidence of Nonalcoholic Fatty Liver Disease in Children: 2009-2018. | 2020 | Details |
| A05541 | 33214165 | Gut | MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis. | 2020 | Details |
| A05542 | 33214063 | Dig Liver Dis | Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP). | 2020 | Details |
| A05543 | 33213977 | Clin Nutr | ESPEN practical guideline: Clinical nutrition in liver disease. | 2020 | Details |
| A05544 | 33213837 | Biochem Biophys Res Commun | NLRP3 inflammasome inhibitor CY-09 reduces hepatic steatosis in experimental NAFLD mice. | 2020 | Details |
| A05545 | 33213187 | Expert Rev Gastroenterol Hepatol | Role of histone deacetylase on nonalcoholic fatty liver disease. | 2020 | Details |
| A05546 | 33212947 | Nutrients | Fructose, Omega 3 Fatty Acids, and Vitamin E: Involvement in Pediatric Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A05547 | 33212187 | Biochim Biophys Acta Mol Basis Dis | Vesicular ATP release from hepatocytes plays a role in the progression of nonalcoholic steatohepatitis. | 2020 | Details |
| A05548 | 33212070 | Metabolism | MAFLD and risk of CKD. | 2020 | Details |
| A05549 | 33211913 | Vopr Pitan | [Effect of carnosine and α-lipoic acid on hepatocyte apoptosis and the cytokine profile in induced fatty liver disease in Wistar rats]. | 2020 | Details |
| A05550 | 33210603 | Elife | CB1R regulates soluble leptin receptor levels via CHOP, contributing to hepatic leptin resistance. | 2020 | Details |
| A05551 | 33208891 | Cell Death Differ | RIP1 kinase activity promotes steatohepatitis through mediating cell death and inflammation in macrophages. | 2020 | Details |
| A05552 | 33208407 | Gut | Sphingomyelin synthase 1 mediates hepatocyte pyroptosis to trigger non-alcoholic steatohepatitis. | 2020 | Details |
| A05553 | 33208241 | Med Hypotheses | Treatment of nonalcoholic fatty liver disease with an anti-osteoporotic medication: A hypothesis on drug repurposing. | 2020 | Details |
| A05554 | 33207932 | Arterioscler Thromb Vasc Biol | Phenotypic Differences Between Polygenic and Monogenic Hypobetalipoproteinemia. | 2020 | Details |
| A05555 | 33207858 | Eur J Histochem | The selective blockade of metabotropic glutamate receptor-5 attenuates fat accumulation in an <em>in vitro</em> model of benign steatosis. | 2020 | Details |
| A05556 | 33207561 | Int J Mol Sci | EZH2 as a Potential Target for NAFLD Therapy. | 2020 | Details |
| A05557 | 33207115 | Clin Mol Hepatol | Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective. | 2020 | Details |
| A05558 | 33206859 | Arq Gastroenterol | INSULIN AND INSULIN RECEPTOR GENE POLYMORPHISMS AND SUSCEPTIBILITY TO NONALCOHOLIC FATTY LIVER DISEASE. | 2020 | Details |
| A05559 | 33205999 | Am J Physiol Gastrointest Liver Physiol | GPCRs get fatty: the role of G protein-coupled receptor signaling in the development and progression of nonalcoholic fatty liver disease. | 2020 | Details |
| A05562 | 33205261 | Curr Gastroenterol Rep | Endobariatrics and Metabolic Endoscopy: Can We Solve the Obesity Epidemic with Our Scope? | 2020 | Details |
| A05563 | 33204823 | Transplant Direct | Characterization of Gut Microbiome in Liver Transplant Recipients With Nonalcoholic Steatohepatitis. | 2020 | Details |
| A05564 | 33204721 | Biomed Res Int | A Nomogram Model Based on Noninvasive Bioindicators to Predict 3-Year Risk of Nonalcoholic Fatty Liver in Nonobese Mainland Chinese: A Prospective Cohort Study. | 2020 | Details |
| A05565 | 33204683 | Biomed Res Int | Research on the Mechanism of Qushi Huayu Decoction in the Intervention of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking Technology. | 2020 | Details |
| A05566 | 33204675 | Can J Gastroenterol Hepatol | Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand? | 2020 | Details |
| A05567 | 33204666 | Clin Nutr Res | A Randomized, Double-Blind, Placebo-Controlled, Multi-Centered Clinical Study to Evaluate the Efficacy and Safety of Artemisia annua L. Extract for Improvement of Liver Function. | 2020 | Details |
| A05568 | 33204402 | Oxid Med Cell Longev | Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NFκB Signaling Pathway and Restores Gut Microbiota in High-Fat-Diet-Fed Mice. | 2020 | Details |
| A05569 | 33203939 | Cell Mol Immunol | Immunopathobiology and therapeutic targets related to cytokines in liver diseases. | 2020 | Details |
| A05570 | 33203828 | Med Sci Monit | Altered Inflammatory Pathway but Unaffected Liver Fibrosis in Mouse Models of Nonalcoholic Steatohepatitis Involving Interleukin-1 Receptor-Associated Kinase 1 Knockout. | 2020 | Details |
| A05571 | 33203257 | Int J Food Sci Nutr | Hepatoprotective and anti-inflammatory effects of a standardized pomegranate (Punica granatum) fruit extract in high fat diet-induced obese C57BL/6 mice. | 2020 | Details |
| A05572 | 33203192 | Metabolites | Metabolic Syndrome and Abnormal Peri-Organ or Intra-Organ Fat (APIFat) Deposition in Chronic Obstructive Pulmonary Disease: An Overview. | 2020 | Details |
| A05573 | 33203174 | Nutrients | Nutraceutical Properties of Polyphenols against Liver Diseases. | 2020 | Details |
| A05574 | 33203036 | Int J Mol Sci | ASC, IL-18 and Galectin-3 as Biomarkers of Non-Alcoholic Steatohepatitis: A Proof of Concept Study. | 2020 | Details |
| A05575 | 33202851 | Antioxidants (Basel) | Antioxidant Lifestyle, Co-Morbidities and Quality of Life Empowerment Concerning Liver Fibrosis. | 2020 | Details |
| A05576 | 33202693 | Int J Mol Sci | IL-18 but Not IL-1 Signaling Is Pivotal for the Initiation of Liver Injury in Murine Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A05577 | 33202166 | J Med Food | Water Extract of Artemisia annua L. Exhibits Hepatoprotective Effects Through Improvement of Lipid Accumulation and Oxidative Stress-Induced Cytotoxicity. | 2020 | Details |
| A05579 | 33201570 | J Gastroenterol Hepatol | The association between non-alcoholic fatty liver disease (with or without metabolic syndrome) and extrahepatic cancer development. | 2020 | Details |
| A05580 | 33200549 | Basic Clin Pharmacol Toxicol | Salsalate reverses metabolic disorders in a mouse model of non-alcoholic fatty liver disease through AMPK activation and caspase-6 activity inhibition. | 2020 | Details |
| A05581 | 33200507 | J Diabetes | Association between nonalcoholic fatty liver and increased low-level albuminuria in postmenopausal women in China: A cross-sectional study. | 2020 | Details |
| A05582 | 33200017 | World J Hepatol | PNPLA3 and TM6SF2 polymorphisms in Brazilian patients with nonalcoholic fatty liver disease. | 2020 | Details |
| A05583 | 33200011 | World J Hepatol | Metabolic syndrome and liver disease in the era of bariatric surgery: What you need to know! | 2020 | Details |
| A05584 | 33199780 | Nat Commun | AdipoR1/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis. | 2020 | Details |
| A05585 | 33199152 | Eur J Med Chem | From off-to on-target: New BRAF-inhibitor-template-derived compounds selectively targeting mitogen activated protein kinase kinase 4 (MKK4). | 2020 | Details |